Shares of Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) rose 5.3% during mid-day trading on Friday . The company traded as high as $2.00 and last traded at $2.00. 12,600 shares were traded during mid-day trading, an increase of 264% from the average session volume of 3,463 shares. The stock had previously closed at $1.90.
Mayne Pharma Group Stock Up 5.3%
The company’s 50 day moving average is $1.75 and its 200-day moving average is $1.78.
About Mayne Pharma Group
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
